Acadia Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Acadia Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Acadia Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Acadia Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Acadia Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Acadia Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Stephen R. Biggar, MD, PhD
Chairman Executive BoardDr. Stephen R. Biggar has been the Chairman of the company since 2016. Prior to this, he served as the Director of the company since 2013. Dr. Biggar is a partner at Baker Brothers Investments, a fund management company. Previously, he served as a Principal with Baker Brothers Investments. He also served as a Director for Synageva BioPharma Corp.
Catherine Owen Adams
Chief Executive Officer; Director Executive BoardMs. Catherine Owen Adams has been the Chief Executive Officer and Director of the company since 2024. Prior to this, she served as the Senior Vice President and General Manager, US at Bristol Myers Squibb. Previously, she served as the Senior Vice President, Head of Major Markets at BMS
Mark C. Schneyer
Executive Vice President; Chief Financial Officer Senior ManagementMr. Mark Schneyer has been the Chief Financial Officer and Executive Vice President of the company since 2021. Prior to this, he served as the Interim Chief Financial Officer of the company. Mr. Schneyer also served as the Senior Vice President, Business Development and Chief Business Officer of the company since 2020. Previously, he served as the Vice President, Business Development, for the Upjohn division at Pfizer Inc.
Konstantina Katcheves
Chief Strategy Officer; Chief Business Officer Senior ManagementMs. Konstantina Katcheves has been the Chief Strategy Officer and Chief Business Officer of the company since 2025. Prior to this, she served as Senior Vice President of Global Business Development of Teva Pharmaceuticals. Ms. Katcheves served as interim Head of Enterprise Strategy and Business Development of Bristol Myers Squibb.
Jennifer J. Rhodes
Secretary; Chief Legal Officer; Executive Vice President Senior ManagementMs. Jennifer J. Rhodes has been the Chief Legal Officer, Executive Vice President, and Secretary of the company since January 2024. Prior to this, she served as the Executive Vice President, General Counsel, and Chief Business Officer of Angion Biomedica. Ms. Rhodes also served as the General Counsel, Chief Business Officer, and Corporate Secretary of Adamas Pharmaceuticals. Previously, she served in executive legal and compliance roles at Medivation and senior legal roles at Pfizer.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer